Lotus Eye Hospital and Institute Ltd

Lotus Eye Hospital and Institute Results Update

Lotus Eye Hospital reported Q2 FY27 revenue of ₹17.72 crore, up 36%, with net profit of ₹43.95 lakh. Half-year net profit rose 59% to ₹1.05 crore.

Lotus Eye Hospital and Institute Q2 FY27 Results: Net Profit ₹0.4 Cr, Up 300.0% YoY

Lotus Eye Hospital approved unaudited quarterly results for September 2026. Quarter net profit was Rs.43.95 lakhs on revenue of Rs.1,772.41 lakhs.

Key figure

Net profit ₹0.4 Cr · +300.0% YoY

Lotus Eye Hospital and Institute Board Meeting Date

Lotus Eye Hospital intimated that its Board meeting is scheduled for 11/11/2026 to consider unaudited Q2/H1 results. The trading window will reopen after results declaration.

Lotus Eye Hospital and Institute Capacity Expansion

Lotus Eye Hospital opened its 11th branch at Erode, Tamil Nadu, commencing operations on October 30, 2026. The branch was inaugurated with state government ministers and local MLAs in attendance.

new branches

1.0 branches

Lotus Eye Hospital and Institute Other Announcement

The company submitted its quarterly shareholding pattern for the period ended September 30, 2026, in accordance with Regulation 31(1)(b) of SEBI LODR.

Lotus Eye Hospital and Institute Annual General Meeting

Lotus Eye Hospital And Institute Limited held its 29th Annual General Meeting on September 23, 2026, via video conferencing to discuss company operations and financial highlights.

Lotus Eye Hospital and Institute Annual General Meeting

Lotus Eye Hospital and Institute Limited will hold its 29th Annual General Meeting on September 23, 2026. The company has dispatched the Notice and Annual Report for FY 2025-26.

Lotus Eye Hospital and Institute Capacity Expansion

Lotus Eye Hospital and Institute Limited launched 'Lotus Optique', a new optical retail store in Coimbatore. The facility integrates professional eye care with quality eyewear products.

Lotus Eye Hospital and Institute Q1 FY27 Results: Net Profit ₹0.6 Cr, Up 20.0% YoY

Lotus Eye Hospital and Institute Ltd reported revenue from operations of ₹17.1 Cr (+26.7% YoY) and net profit of ₹0.6 Cr (+20.0% YoY) for Q1 FY27.

Key figure

Net profit ₹0.6 Cr · +20.0% YoY

Lotus Eye Hospital and Institute Board Meeting Date

Lotus Eye Hospital and Institute will hold a board meeting on August 10, 2026, to approve the company's standalone unaudited financial results for the June quarter.

Lotus Eye Hospital and Institute Other Announcement

Lotus Eye Hospital submitted its Annual Secretarial Compliance Report for FY2026. A ₹1.02 Crore fine was paid for delayed shareholder approval regarding a director's appointment.

Value

₹1.02 Cr

Execution

Financial Year ended March 31, 2026

Lotus Eye Hospital and Institute Management Change

Lotus Eye Hospital re-appointed Mr. P Vishnu Adithan as Internal Auditor for a twelve-month term. The appointment follows board approval effective from April 1, 2026.

Execution

12 months

Lotus Eye Hospital and Institute Q4 FY26 Results: Net Loss of ₹0.3 Cr

Lotus Eye Hospital and Institute Ltd reported revenue from operations of ₹13.6 Cr (+18.3% YoY) and a net loss of ₹0.3 Cr for Q4 FY26.

Key figure

Net loss ₹0.3 Cr

Lotus Eye Hospital and Institute Financial Results

Lotus Eye Hospital reported annual total income of ₹54.89 Crore for FY2026. The board also reappointed Mr. P Vishnu Adithan as Internal Auditor for FY2026-27.

Value

₹54.89 Cr

Lotus Eye Hospital and Institute Board Meeting Date

Lotus Eye Hospital scheduled a board meeting for May 26, 2026, to approve fiscal year-end financial results. The trading window remains closed for 48 hours post-declaration.

Lotus Eye Hospital and Institute Promoter Buying (Off-Market)

Promoter Sangeetha Sundaramoorthy acquired 14,28,571 shares via an inter-se transfer, increasing her stake to 35.01%. This internal restructuring consolidates promoter-group holding within the company.

Lotus Eye Hospital and Institute Debt & Borrowing

Lotus Eye Hospital and Institute Limited confirmed it does not meet the 'Large Corporate' criteria as of March 31, 2026. This disclosure complies with SEBI's framework for fund raising via debt securities by large entities.

Lotus Eye Hospital and Institute Other Announcement

Lotus Eye Hospital and Institute Ltd submitted its compliance certificate under SEBI Regulation 74(5) for the quarter ended March 31, 2026. The filing confirms that securities received for dematerialization have been verified, mutilated, and cancelled. This is a routine regulatory disclosure regarding share record maintenance.